Tag

#Asco 2026

2 articles

HealthMedical Research

Moderna and Merck's mRNA vaccine reduced melanoma recurrence risk by 49% over five years, offering new hope for advanced skin cancer patients.

June 3, 2026—4 min read

Health & BiotechnologyEconomy

Chinese biotech firms set records at ASCO 2026 with 95 abstracts and a $10.5B Pfizer-Innovent deal, fueling concerns over US drug dominance.

May 30, 2026—5 min read